0.30
+0.0136(+4.76%)
Currency In USD
Address
75 Hayden Avenue
Lexington, MA 02421
United States of America
Phone
781 315 4600
Website
Sector
Healthcare
Industry
Biotechnology
Employees
46
First IPO Date
October 03, 2019
| Name | Title | Pay | Year Born |
| Dr. Carl P. LeBel Ph.D. | Chief Devel. Officer | 633,404 | 1959 |
| Ms. Wendy S. Arnold | Chief People Officer | 0 | 1973 |
| Mr. Jason Glashow | Senior Vice President of Corporation Affairs | 0 | N/A |
| Dr. Lisa Geller J.D., Ph.D. | Senior Vice President of Intellectual Property | 0 | N/A |
| Mr. James P. Abely | Associate General Counsel & Secretary | 0 | N/A |
| Dr. Quentin McCubbin Ph.D. | Chief Manufacturing Officer | 0 | 1970 |
| Dr. William W. Chin M.D. | Senior Vice President of Translational Medicine | 0 | 1948 |
| Dr. Dana C. Hilt M.D. | Chief Medical Officer (acting) | 0 | 1953 |
| Ms. Susan Stewart J.D., L.L.M. | Chief Regulatory Officer | 0 | 1961 |
| Mr. Richard J. Mitrano | Vice President of Finance & Operations | 0 | 1971 |
| Dr. John L. LaMattina Ph.D. | Senior Advisor & Member of PCA Regenerative Medicine Advisory Board | 0 | 1950 |
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.